- Kidney cancer is the eighth most common cancer in the UK.
- Around 10,100 people in the UK were diagnosed with kidney cancer in 2011, that’s 28 every day.
- Kidney cancer is the seventh most common cancer in men in the UK, with around 6,300 new cases diagnosed in the UK in 2011.
- Kidney cancer is the 10th most common cancer in women in the UK, with around 3,900 new cases diagnosed in the UK in 2011.
- Three-quarters of new cases of kidney cancer are diagnosed in people aged 60 and over.
- Kidney cancer incidence rates in Britain have more than doubled since the mid-1970s.
- In the last ten years kidney cancer incidence rates in the UK have increased by almost a third.
- In Europe, more than 115,000 new cases of kidney cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 19th lowest in Europe for males and 17th highest for females.
- Worldwide, around 338,000 people were diagnosed with kidney cancer in 2012, with incidence rates varying across the world.
Kidney cancer statistics
New cases of kidney cancer, 2011, UK
Deaths from kidney cancer, 2012, UK
Survive kidney cancer for 10 or more years, 2010-11, England and Wales
Preventable cases of kidney cancer, UK
- Kidney cancer is the fourteenth most common cause of cancer death in the UK.
- Around 4,300 people died from kidney cancer in 2012 in the UK, that’s more than 11 people every day.
- Three-quarters of deaths from kidney cancer are in people aged 65 and over.
- Since the early-1970s, kidney cancer death rates in the UK have increased by half.
- In Europe, around 49,000 people were estimated to have died from kidney cancer in 2012. The UK mortality rate is 20th lowest in Europe for males and 12th highest for females.
- Worldwide, more than 143,000 people were estimated to have died from kidney cancer in 2012, with mortality rates varying across the world.
- Half of people diagnosed with kidney cancer are now likely to survive their disease for at least ten years.
- More than half of people diagnosed with kidney cancer survive their disease for at least five years after diagnosis.
- Ten-year survival for kidney cancer has more than doubled in the last forty years.
- 42% (47% in males and 34% in females) of kidney cancer cases each year in the UK are linked to major lifestyle and other risk factors.
- A person’s risk of developing kidney cancer depends on many factors, including age,genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- An estimated 42% of kidney cancers in the UK are linked to lifestyle factors including smoking (24%) and overweight and obesity (24%).
- Ionising radiation, certain occupational exposures, and certain medicines cause kidney cancer.
- Certain medical conditions and inadequate physical activity may relate to higher kidney cancer risk.
The latest statistics available for kidney cancer in the UK are; incidence 2011, mortality 2012 and survival 2010-2011.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Survival by stage is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past. Survival by stage is available for the former Anglia Cancer Network in the east of England, however. The former Anglia Cancer Network covers around 5% of the population of England and may not be representative of the country as a whole due to differences in underlying demographic factors (such as age, deprivation or ethnicity), as well as variation in local healthcare provision standards and policies.
Risk factor evidence is for renal cell carcinoma (RCC) unless otherwise specified. Meta-analyses and
You are welcome to reuse this Cancer Research UK statistics content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.